Sector revisions Prime Medicine, Inc.

Equities

Market Closed - Nasdaq Other stock markets 06:00:00 16/04/26 am AEST			5-day change	1st Jan Change
3.790 ^USD	+2.43%		+7.06%	+9.22%

19/03	Prime Medicine, Inc. Presents at The Citizens Life Sciences Conference 2026, Mar-11-2026 02:15 PM
12/03	Oppenheimer Initiates Prime Medicine at Outperform With $11 Price Target	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
PRIME MEDICINE, INC.				9
ARGENX SE				15
WUXI APPTEC CO., LTD.				18
INSMED INCORPORATED				20
BIONTECH SE				18
WUXI BIOLOGICS (CAYMAN) INC.				21
GENMAB A/S				14
AKESO, INC.				20
SUMMIT THERAPEUTICS INC.				14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.				17
MADRIGAL PHARMACEUTICALS, INC.				14
EXELIXIS, INC.				18
REMEGEN CO., LTD.				15
ARROWHEAD PHARMACEUTICALS, INC.				11
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	-	1
VAXCYTE, INC.				9
NUVALENT, INC.				18
CYTOKINETICS, INCORPORATED				18
IMMUNITYBIO, INC.				5
Average				14
Weighted average by Cap.				16